Target Name: DLGAP4
NCBI ID: G22839
Review Report on DLGAP4 Target / Biomarker Content of Review Report on DLGAP4 Target / Biomarker
DLGAP4
Other Name(s): Disks large-associated protein 4 (isoform a) | DLGAP4 variant 1 | KIAA0964 | DLGAP4 variant 2 | DLG associated protein 4 | Disks large-associated protein 4 (isoform b) | PSD-95/SAP90-binding protein 4 | RP5-977B1.6 | DAP-4 | Disks large-associated protein 4 | DLG associated protein 4, transcript variant 2 | DLGP4_HUMAN | MGC131862 | DAP4 | Disks large associated protein 4 | FLJ20588 | SAPAP-4 | DLG associated protein 4, transcript variant 1 | SAP90/PSD-95-associated protein 4 | Disks large-associated protein 4 isoform b | DLP4 | SAPAP4 | discs large homolog associated protein 4

Understanding DLGAP4: A Potential Drug Target and Biomarker

DLGAP4 (Disks large-associated protein 4 (isoform a)) is a protein that is expressed in a variety of tissues throughout the body, including the brain, heart, and kidneys. It is a member of the large-associated protein (LAP) family, which includes proteins that play important roles in various cellular processes, including cell signaling, DNA replication, and protein transport.

One of the unique features of DLGAP4 is its ability to form large, association domains, which are regions of the protein that are able to interact with other proteins. These domains can be used to form complex structures with other proteins, which can enhance the protein's stability and influence its function.

DLGAP4 has been shown to play a role in a variety of cellular processes, including the regulation of cell signaling pathways, such as the messenger RNA-directed cell proliferation and cell death processes, and the regulation of protein translation. It has also been shown to be involved in the development and maintenance of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

As a potential drug target, DLGAP4 is being studied for its potential therapeutic applications in a variety of diseases. For example, some studies have suggested that inhibiting the activity of DLGAP4 may be a promising strategy for treating cancer, as it has been shown to be involved in the regulation of cancer cell growth and survival.

In addition to its potential therapeutic applications, DLGAP4 is also being studied as a biomarker for various diseases. For example, some studies have suggested that changes in the levels of DLGAP4 may be associated with the development of certain diseases, such as cancer and neurodegenerative disorders..

Overall, DLGAP4 is a protein that has significant potential as a drug target and biomarker. Further research is needed to fully understand its role in various cellular processes and to develop effective therapies based on its properties.

Protein Name: DLG Associated Protein 4

Functions: May play a role in the molecular organization of synapses and neuronal cell signaling. Could be an adapter protein linking ion channel to the subsynaptic cytoskeleton. May induce enrichment of PSD-95/SAP90 at the plasma membrane

The "DLGAP4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DLGAP4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

DLGAP5 | DLK1 | DLK2 | DLL1 | DLL3 | DLL4 | DLST | DLSTP1 | DLX1 | DLX2 | DLX2-DT | DLX3 | DLX4 | DLX5 | DLX6 | DLX6-AS1 | DM1-AS | DMAC1 | DMAC2 | DMAC2L | DMAP1 | DMBT1 | DMBT1L1 | DMBX1 | DMC1 | DMD | DMGDH | DMKN | DMP1 | DMPK | DMRT1 | DMRT2 | DMRT3 | DMRTA1 | DMRTA2 | DMRTB1 | DMRTC1 | DMRTC1B | DMRTC2 | DMTF1 | DMTF1-AS1 | DMTN | DMWD | DMXL1 | DMXL2 | DNA ligase | DNA Methyltransferase (DNMT) | DNA Polymerase alpha | DNA polymerase delta | DNA Polymerase epsilon | DNA Polymerase gamma | DNA Polymerase zeta Complex | DNA primase | DNA topoisomerase | DNA Topoisomerase II | DNA-Dependent Protein Kinase (DNA-PK) | DNA-Directed DNA Polymerase Complex | DNA-Directed RNA Polymerase | DNA-Directed RNA Polymerase I | DNA-Directed RNA Polymerase II | DNA-directed RNA polymerase II, core complex | DNA-directed RNA polymerase III | DNA2 | DNAAF1 | DNAAF10 | DNAAF11 | DNAAF2 | DNAAF3 | DNAAF4 | DNAAF4-CCPG1 | DNAAF5 | DNAAF6 | DNAAF8 | DNAAF9 | DNAH1 | DNAH10 | DNAH11 | DNAH12 | DNAH14 | DNAH17 | DNAH17-AS1 | DNAH2 | DNAH3 | DNAH5 | DNAH6 | DNAH7 | DNAH8 | DNAH8-AS1 | DNAH9 | DNAI1 | DNAI2 | DNAI3 | DNAI4 | DNAI7 | DNAJA1 | DNAJA1P3 | DNAJA1P4 | DNAJA1P5 | DNAJA2 | DNAJA3